GPHARMA

Neupré ·KBO/BCE: BE 1000.994.171

Loading dossier…

Checked · Insight, alerts and connections for every Belgian company, from official sources.

NL FR EN

Product

Search companies Sectors Radar Live Compare Prospects Supplier check Feasibility

Data & registers

Insolvencies Curators Directors Director bans Protection orders Notaries News

Account

Watchlist Portfolio Alerts Pricing

Checked

About Methodology Knowledge base Sources FAQ Help API Badge

Legal

Privacy Terms Contact

Checked AI

Open a company dossier to ask Checked AI about it.

Answers from Checked AI. Not legal advice.

Metric	This company	Sector median	Position in the sector
Solvency	10.3%	17.4%	better than 38% of 855 sector peers
Net result	€71k	€15k	better than 71% of 856 sector peers
Equity	€171k	€100k	better than 60% of 857 sector peers
Gross operating margin	€92k	€213k	better than 30% of 784 sector peers
Total assets	€1.66M	€767k	better than 74% of 856 sector peers

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€1.66M
Fixed assets	21/28	€1.55M
Financial fixed assets	28	€1.55M
Current assets	29/58	€110k
Amounts receivable within one year	40/41	€6
Cash & bank	54/58	€110k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€1.66M
Equity	10/15	€171k
Contributions / capital	10/11	€100k
Accumulated profits (losses)	14	€71k
Amounts payable	17/49	€1.49M
Amounts payable after one year	17	€1.10M
Amounts payable within one year	42/48	€388k
Trade debts payable within one year	44	€0
Income statement
Gross operating margin	9900	€92k
Operating result	9901	€92k
Financial charges	65	€3k
Result before taxes	9903	€89k
Income taxes	67/77	€18k
Net result for the period	9904	€71k
Result to be appropriated	9905	€71k

Summary